UBS Group’s GMO US Value ETF GMOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.47K Buy
+205
New +$6.55K ﹤0.01% 9410
2026
Q2
– Sell
-271
Closed -$7.61K – 11286
2026
Q1
$7.61K Buy
+271
New +$7.72K ﹤0.01% 8561
2025
Q3
– Sell
-273
Closed -$6.9K – 11209
2025
Q2
$6.9K Buy
+273
New +$6.53K ﹤0.01% 9057
2025
Q1
– Sell
-615
Closed -$15K – 10903
2024
Q4
$15K Buy
+615
New +$15.6K ﹤0.01% 8058

Other funds holding GMOV

UBS Group's GMOV Position: Q3 2026 in Review

UBS Group opened a new position in GMO US Value ETF (GMOV) in Q3 2026: 205 shares worth $6.47K. The stake represents ﹤0.01% of the portfolio and ranks #9410 among its holdings. This is a return to the name: UBS Group previously reported a position in GMOV as recently as Q1 2026.

UBS Group first reported a position in GMOV in Q4 2024 and has held it in 4 quarters since. The position peaked at $15K in Q4 2024. 22 funds tracked by Wall St. Rank hold GMOV as of Q3 2026.

  • UBS Group held 205 shares of GMO US Value ETF worth $6.47K as of Q3 2026.
  • GMO US Value ETF was a new UBS Group position in Q3 2026.
  • GMO US Value ETF made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #9410 holding.
  • UBS Group first reported a position in GMO US Value ETF in Q4 2024 and has held it in 4 quarters since.
  • UBS Group's GMO US Value ETF position peaked at $15K in Q4 2024.
  • 22 funds tracked by Wall St. Rank held GMO US Value ETF as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.